{
    "code": "02022226",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022226",
    "time": "2020-02-25 12:52:10",
    "許可證字號": "衛署藥輸字第022226號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/05\/31",
    "註銷理由": "屆期未申請展延",
    "有效日期": "97\/07\/06",
    "發證日期": "87\/07\/06",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202222602",
    "中文品名": "克札平",
    "英文品名": "CLOZAPINE",
    "適應症": "精神分裂症",
    "劑型": "043原料藥結晶性粉末",
    "包裝": "０．５公斤以上",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "01製劑原料",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1801201100  雙隆貿易有限公司",
        "申請商地址": "台北巿大同區承德路三段135號1樓",
        "主製造廠": ""
    },
    "CCC號列": "29332900005 其他之結構中含有一未稠合之咪唑環（不論是否氫化）之化合物Other compounds containing an unfused imidazole ring (whether or not hydrogened) in the structure",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816901600",
            "成分名稱": "CLOZAPINE",
            "含量描述": "99-101",
            "含量": "",
            "單位": "%"
        }
    ]
}